ALVO · Nasdaq, Nasdaq · CIK 0001898416

Alvotech

Alvotech’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 20, 2026. In fiscal 2025 (year ended Dec 31, 2025) it reported revenue of $586.3M and net income of $27.9M, according to its XBRL data on EDGAR. Its EDGAR record lists 0 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$586.3M
Net income, FY2025
$27.9M
Form 4 filings on record, past 12 months
0

Company overview

Legal name (as filed)
Alvotech
Tickers
ALVO, ALVOW
SEC Central Index Key (CIK)
0001898416
Business address
LUXEMBOURG, Luxembourg
State or country of incorporation
Luxembourg
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2084 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Alvotech’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$36.8MFY2021$83.0MFY2022$91.4MFY2023$489.7MFY2024$586.3MFY2025
Net income
-$101.5MFY2021-$513.6MFY2022-$551.7MFY2023-$231.9MFY2024$27.9MFY2025
ALVO annual results
ItemFY2021
ended Dec 31, 2021		FY2022
ended Dec 31, 2022		FY2023
ended Dec 31, 2023		FY2024
ended Dec 31, 2024		FY2025
ended Dec 31, 2025
Revenue$36.8M$83.0M$91.4M$489.7M$586.3M
Net income-$101.5M-$513.6M-$551.7M-$231.9M$27.9M
Diluted EPS-$0.92-$2.60-$2.43-$0.87$0.10
Total assets$598.0M$828.4M$950.1M$1.2B$1.5B
Cash and equivalents$17.6M$66.4M$11.2M$51.4M$172.4M

XBRL tags used: revenue = RevenueFromContractsWithCustomers; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

ALVO latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Mar 31, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Oct 20, 20266-KReport of a foreign private issuer· period Oct 20, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Alvotech, by form type:

6-K ×33SCHEDULE 13D/A ×2424B5 ×2FWP ×220-F ×1
ALVO recent filings
FiledFormWhat it isOriginal
Oct 20, 20266-KReport of a foreign private issuer· period Oct 20, 2026Document · Index
Oct 14, 20266-KReport of a foreign private issuer· period Oct 14, 2026Document · Index
Oct 7, 20266-KReport of a foreign private issuer· period Oct 6, 2026Document · Index
Oct 5, 20266-KReport of a foreign private issuer· period Oct 5, 2026Document · Index
Aug 31, 20266-KReport of a foreign private issuer· period Aug 31, 2026Document · Index
Aug 21, 20266-KReport of a foreign private issuer· period Aug 21, 2026Document · Index
Aug 19, 20266-KReport of a foreign private issuer· period Jun 30, 2026Document · Index
Jul 29, 20266-KReport of a foreign private issuer· period Jul 29, 2026Document · Index
Jul 1, 20266-KReport of a foreign private issuer· period Jul 1, 2026Document · Index
Jun 30, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Jun 18, 20266-KReport of a foreign private issuer· period Jun 18, 2026Document · Index
Jun 17, 20266-KReport of a foreign private issuer· period Jun 16, 2026Document · Index
Jun 16, 2026424B5424B5Document · Index
Jun 16, 2026FWPFWPDocument · Index
Jun 15, 2026FWPFWPDocument · Index
Jun 15, 2026424B5424B5Document · Index
Jun 15, 20266-KReport of a foreign private issuer· period Jun 15, 2026Document · Index
Jun 8, 20266-KReport of a foreign private issuer· period Mar 31, 2026Document · Index
Jun 4, 20266-KReport of a foreign private issuer· period Jun 4, 2026Document · Index
May 11, 20266-KReport of a foreign private issuer· period May 11, 2026Document · Index
May 4, 20266-KReport of a foreign private issuer· period Apr 30, 2026Document · Index
Mar 31, 202620-FAnnual report of a foreign private issuer· period Dec 31, 2025Document · Index
Mar 19, 20266-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Mar 12, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Feb 27, 20266-KReport of a foreign private issuer· period Feb 27, 2026Document · Index
Feb 5, 20266-KReport of a foreign private issuer· period Feb 5, 2026Document · Index
Feb 2, 20266-KReport of a foreign private issuer· period Feb 2, 2026Document · Index
Jan 29, 20266-KReport of a foreign private issuer· period Jan 29, 2026Document · Index
Jan 7, 20266-KReport of a foreign private issuer· period Jan 7, 2026Document · Index
Jan 7, 20266-KReport of a foreign private issuer· period Jan 6, 2026Document · Index
Jan 6, 20266-KReport of a foreign private issuer· period Jan 6, 2026Document · Index
Jan 2, 20266-KReport of a foreign private issuer· period Dec 31, 2025Document · Index
Dec 23, 20256-KReport of a foreign private issuer· period Dec 22, 2025Document · Index
Dec 19, 20256-KReport of a foreign private issuer· period Dec 19, 2025Document · Index
Dec 17, 20256-KReport of a foreign private issuer· period Dec 17, 2025Document · Index
Nov 24, 20256-KReport of a foreign private issuer· period Nov 24, 2025Document · Index
Nov 20, 20256-KReport of a foreign private issuer· period Nov 20, 2025Document · Index
Nov 17, 20256-KReport of a foreign private issuer· period Nov 12, 2025Document · Index
Nov 12, 20256-KReport of a foreign private issuer· period Nov 10, 2025Document · Index
Nov 6, 20256-KReport of a foreign private issuer· period Nov 6, 2025Document · Index

Insider filing activity

0 Form 4 filings appear in Alvotech’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Biological Products, (No Diagnostic Substances)

All 61 companies in Biological Products, (No Diagnostic Substances)

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001898416 and XBRL company facts. Alvotech on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.